Antibe Therapeutics Financials
| ATBPF Stock | USD 0.22 0.00 0.00% |
Antibe |
Understanding current and past Antibe Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Antibe Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Antibe Therapeutics' assets may result in an increase in income on the income statement.
Antibe Therapeutics Stock Summary
Antibe Therapeutics competes with Grey Cloak. Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 15 Prince Arthur |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.antibethera.com |
| Phone | 416 922 3460 |
| Currency | USD - US Dollar |
Antibe Therapeutics Key Financial Ratios
There are many critical financial ratios that Antibe Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Antibe Therapeutics reports annually and quarterly.| Return On Equity | -0.4 | |||
| Return On Asset | -0.16 | |||
| Target Price | 4.53 | |||
| Number Of Employees | 37 | |||
| Beta | 0.0997 |
Antibe Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Antibe Therapeutics's current stock value. Our valuation model uses many indicators to compare Antibe Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Antibe Therapeutics competition to find correlations between indicators driving Antibe Therapeutics's intrinsic value. More Info.Antibe Therapeutics is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Antibe Therapeutics' earnings, one of the primary drivers of an investment's value.Antibe Therapeutics Systematic Risk
Antibe Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Antibe Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Antibe Therapeutics correlated with the market. If Beta is less than 0 Antibe Therapeutics generally moves in the opposite direction as compared to the market. If Antibe Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Antibe Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Antibe Therapeutics is generally in the same direction as the market. If Beta > 1 Antibe Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Antibe Pink Sheet analysis
When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |